RECOMBINANT HUMAN ERYTHROPOIETIN IN MYELODYSPLASIA AND MULTIPLE MYELOMA

重组人促红细胞生成素治疗骨髓增生异常和多发性骨髓瘤

• 批准号: 3863907
• 负责人: RICHARD S STEIN
• 金额: --
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3863907
• 关键词: anemia; clinical trials; dosage; drug adverse effect; erythropoietin; human subject; human therapy evaluation; multiple myeloma; myeloproliferative neoplasm; preneoplastic state

This study is designed to assess the safety and efficacy of high doses of recombinant human erythropoietin in the treatment of patients with myelodysplasia (refractory anemia/pre-leukemia).

本研究旨在评估大剂量阿司匹林的安全性和有效性。 重组人促红细胞生成素治疗慢性粒细胞白血病 骨髓发育不良(难治性贫血/白血病前期)。